GFRena2® probiotics

GFRena2® is a functional probiotic technology-transferred through a collaboration between GeneFerm Biotech and National Taiwan University. It features two premium strains—Lactobacillus plantarum and Lactobacillus paracasei—carefully selected from traditional fermented dairy products of Mongolia. These strains help support a balanced gut microbiota and promote healthy metabolism, contributing to daily circulatory wellness.

Enhanced with our patented Labcot® microencapsulation technology, GFRena2® protects probiotic viability by shielding the strains from stomach acid and digestive enzymes. It also incorporates the innovative Proalive® rapid-freezing technology, which significantly reduces ice crystal formation and helps maintain probiotic activity. Designed for the modern lifestyle, GFRena2® integrates science, patented innovation, and clinical validation to support health and open up new business opportunities.

 
Patents & Recognitions
✔ Taiwan Patent: Probiotic composition and its applications (I770811)
✔ US Patent: Probiotic composition and its applications (US 12,220,436 B2)
✔ Published in 5 international scientific journals
✔ Taiwan Patent: Lacot Triple-Layer Microencapsulation Technology (M585622)
✔ Taiwan Patent: Lactic Acid Bacteria Identification System (M578702)
✔ Taiwan & Japan Patents: ProAlive Liquid Nitrogen Rapid-Freezing Technology (M662047)